WASHINGTON, D.C. — The U.S. Food and Drug Administration announced that more than 140,000 bottles of a widely used generic cholesterol drug, atorvastatin calcium, are being voluntarily recalled because they may not dissolve properly, potentially reducing their effectiveness.

The FDA’s Enforcement Report documents a voluntary Class II recall of certain lots of atorvastatin calcium due to dissolution failures in laboratory tests.

The recall affects multiple dosage strengths and package sizes. The recalling firm is Ascend Laboratories in New Jersey, and the implicated product was manufactured by a third party (Alkem Laboratories). # Product Description Recall Number Classification Code Information Product Quantity Reason for Recall 1 Atorvastatin Calcium Tablets USP, 10 mg, Rx Only a)

See Full Page